Probiotics: a perspective on problems and pitfalls

Typeset version

 

TY  - JOUR
  - Shanahan, F.
  - 2003
  - Scand J Gastroenterol Supplscand J Gastroenterol Suppl
  - Probiotics: a perspective on problems and pitfalls
  - Validated
  - ()
  - 237237
  - 34
  - 6
  - Therapeutic manipulation of gut flora with probiotics promises to be a useful strategy for several disorders, including infectious, inflammatory and neoplastic conditions. However, there are large gaps in the knowledge of the normal flora and of the optimal use of probiotic products. At present, there is no reliable in vitro predictor of in vivo efficacy of putative probiotics. Indeed, probiotic performance should be defined in the context of the disease indication for which it is intended. This will require rigorous prospective clinical trials. In addition, guidelines for routine clinical use of probiotics are confounded by insufficient data on optimum strain selection, dose, delivery vehicle and monitoring. Before the promise can be fulfilled, problems and potential pitfalls with probiotic therapy need resolution.Therapeutic manipulation of gut flora with probiotics promises to be a useful strategy for several disorders, including infectious, inflammatory and neoplastic conditions. However, there are large gaps in the knowledge of the normal flora and of the optimal use of probiotic products. At present, there is no reliable in vitro predictor of in vivo efficacy of putative probiotics. Indeed, probiotic performance should be defined in the context of the disease indication for which it is intended. This will require rigorous prospective clinical trials. In addition, guidelines for routine clinical use of probiotics are confounded by insufficient data on optimum strain selection, dose, delivery vehicle and monitoring. Before the promise can be fulfilled, problems and potential pitfalls with probiotic therapy need resolution.
  - 0085-5928 (Print) 0085-59
DA  - 2003/NaN
ER  - 
@article{V280546933,
   = {Shanahan,  F. },
   = {2003},
   = {Scand J Gastroenterol Supplscand J Gastroenterol Suppl},
   = {Probiotics: a perspective on problems and pitfalls},
   = {Validated},
   = {()},
   = {237237},
  pages = {34--6},
   = {{Therapeutic manipulation of gut flora with probiotics promises to be a useful strategy for several disorders, including infectious, inflammatory and neoplastic conditions. However, there are large gaps in the knowledge of the normal flora and of the optimal use of probiotic products. At present, there is no reliable in vitro predictor of in vivo efficacy of putative probiotics. Indeed, probiotic performance should be defined in the context of the disease indication for which it is intended. This will require rigorous prospective clinical trials. In addition, guidelines for routine clinical use of probiotics are confounded by insufficient data on optimum strain selection, dose, delivery vehicle and monitoring. Before the promise can be fulfilled, problems and potential pitfalls with probiotic therapy need resolution.Therapeutic manipulation of gut flora with probiotics promises to be a useful strategy for several disorders, including infectious, inflammatory and neoplastic conditions. However, there are large gaps in the knowledge of the normal flora and of the optimal use of probiotic products. At present, there is no reliable in vitro predictor of in vivo efficacy of putative probiotics. Indeed, probiotic performance should be defined in the context of the disease indication for which it is intended. This will require rigorous prospective clinical trials. In addition, guidelines for routine clinical use of probiotics are confounded by insufficient data on optimum strain selection, dose, delivery vehicle and monitoring. Before the promise can be fulfilled, problems and potential pitfalls with probiotic therapy need resolution.}},
  issn = {0085-5928 (Print) 0085-59},
  source = {IRIS}
}
AUTHORSShanahan, F.
YEAR2003
MONTH
JOURNAL_CODEScand J Gastroenterol Supplscand J Gastroenterol Suppl
TITLEProbiotics: a perspective on problems and pitfalls
STATUSValidated
TIMES_CITED()
SEARCH_KEYWORD
VOLUME
ISSUE237237
START_PAGE34
END_PAGE6
ABSTRACTTherapeutic manipulation of gut flora with probiotics promises to be a useful strategy for several disorders, including infectious, inflammatory and neoplastic conditions. However, there are large gaps in the knowledge of the normal flora and of the optimal use of probiotic products. At present, there is no reliable in vitro predictor of in vivo efficacy of putative probiotics. Indeed, probiotic performance should be defined in the context of the disease indication for which it is intended. This will require rigorous prospective clinical trials. In addition, guidelines for routine clinical use of probiotics are confounded by insufficient data on optimum strain selection, dose, delivery vehicle and monitoring. Before the promise can be fulfilled, problems and potential pitfalls with probiotic therapy need resolution.Therapeutic manipulation of gut flora with probiotics promises to be a useful strategy for several disorders, including infectious, inflammatory and neoplastic conditions. However, there are large gaps in the knowledge of the normal flora and of the optimal use of probiotic products. At present, there is no reliable in vitro predictor of in vivo efficacy of putative probiotics. Indeed, probiotic performance should be defined in the context of the disease indication for which it is intended. This will require rigorous prospective clinical trials. In addition, guidelines for routine clinical use of probiotics are confounded by insufficient data on optimum strain selection, dose, delivery vehicle and monitoring. Before the promise can be fulfilled, problems and potential pitfalls with probiotic therapy need resolution.
PUBLISHER_LOCATION
ISBN_ISSN0085-5928 (Print) 0085-59
EDITION
URL
DOI_LINK
FUNDING_BODY
GRANT_DETAILS